MaxVal is a silicon valley-based IP solutions provider known for its cutting edge products and automated solutions. Since 2004, MaxVal has been providing technology-enabled solutions and expert services by partnering with patent counsel and patent operations to optimize patent lifecycle management with high levels of customer service.
Our products make your paralegal and IP operations more efficient and ensure that important inventions and references are captured to support your patent filing team.
From invention capture, docketing to annuity management, Symphony brings all facets of IP management onto one stage.More
Max-IDS™ is a stand-alone software product. Clients have the option to benefit from MaxVal’s cost-effective data migration and data upkeep services.More
With the increasing trend in patent litigation each year, patent litigation analysis is important to understand current and future threats.More
MaxVal account (Max-Insight) gives you access to all the free tools available on our site. We ask for some personal information during sign-up in order to keep your account secure and make sure you have a great experience, no matter which tool you use.More
MaxVal Services are the timely, affordable and flexible way to address your IP related needs. Our highly experienced staff, combination of both onshore and offshore resources, and innovative use of technology make us the right choice for your legal process outsourcing needs.
We combine our onshore and offshore professional staff in a way that precisely meets your needs and provide services that are of the highest quality and the most cost-efficient.More...
High quality patent drawings to meet all PTO requirements for filing utility, design and trademark applications.More...
Be it the PTAB proceedings, a new publication or prosecution status of a patent application or an assignment of a patent, monitor each actions with our custom email alerts.More...
In this issue, we have covered a couple of hot topics that are currently trending in the biotech and cloud-tech industries.
Although CRISPR was known to have an important role in bacterial immunity for over a decade, it is only in the last 5 years that it has garnered interest as a gene editing tool.
The article presents a base editing approach to expand the scope and efficiency of CRISPR mediated genome editing. It highlights recent FDA approval for a trial involving Artificial Intelligence-powered insulin infusion device for diabetes management.
MaxVal is sponsoring the 11th annual event of IP Business Congress Global (IPBC), to be held from June 10-12, 2018 at Palace Hotel, San Francisco.